Streptomyces Details: NCBI 1883, high G+C gram-positive [genus]

| "Microstreptospora" Yan et al.| Actinopycnidium| Actinopycnidium Krasil'nikov 1962| Actinosporangium| Actinosporangium Krasil'nikov and Yuan 1961| Chainia| Chainia Thirumalachar 1955| Elytrosporangium| Elytrosporangium Falcao de Morais et al. 1966| Kitasatoa| Kitasatoa Matsumae and Hata 1968| Microstreptospora| Streptomyces| Streptomyces Waksman and Henrici 1943 (Approved Lists 1980) emend. Wellington et al. 1992| Streptomyces Waksman and Henrici 1943 (Approved Lists 1980) emend. Witt and Stackebrandt 1991| Streptoverticillium| Streptoverticillium Baldacci 1958

  1. Antibiotic Production:

    • Streptomyces species are prolific producers of antibiotics, such as streptomycin, erythromycin, and tetracycline. These antibiotics have been instrumental in medicine for treating bacterial infections in humans, plants, and animals.
  2. Biotechnological Applications:

    • The metabolic versatility of Streptomyces makes them valuable for biotechnological applications. They are used in the production of antibiotics, enzymes, and other bioactive compounds with applications in medicine and industry.
  3. Soil Ecology:

    • Streptomyces bacteria are abundant in soil and play essential roles in decomposing organic matter. They contribute to nutrient cycling in ecosystems and help maintain soil health.
  4. Non-pathogenic in Humans:

    • Streptomyces species are generally not considered human pathogens. While they are part of the normal soil microbiota, direct contact with high concentrations of spores in certain occupational settings may lead to respiratory sensitization in some individuals.
  5. Actinomycetoma:

    • In rare cases, certain Streptomyces species have been associated with actinomycetoma, a chronic subcutaneous infection. This condition is characterized by the formation of localized abscesses and draining sinuses, and it can be caused by various actinomycete bacteria, including some Streptomyces species.
  6. Occupational Exposure:

    • Individuals working in environments with high levels of dust or aerosols containing Streptomyces spores may be at risk of respiratory sensitization. Occupational safety measures are important in settings where exposure to high concentrations of these bacteria is possible.
  7. Agricultural Benefits:

    • Streptomyces species contribute to soil health and may have indirect benefits in agriculture. Some strains exhibit plant growth-promoting effects and can protect plants from certain pathogens.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Streptomyces

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 1.37 6 5300 0 3547 944.2 180 1327.8 0 3160 0 %ile 100 %ile
biomesight 12.03 0 0 10 2022 0 337 52.7 20 145.1 20 80 0 %ile 100 %ile
thorne 100 43 1039 0 672 265.7 185 207.4 75 411 0 %ile 100 %ile
thryve 19.68 0 10 2 189 0 85 31.8 24 27 12 46 0 %ile 100 %ile

External Reference Ranges for Streptomyces

Streptomyces (NCBI 1883) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 0 192.84 0 0.0193
Lab Teletest 0 500 0 0.05
XenoGene 5000 10000 0.5 1
Statistic by Lab Source for Streptomyces
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
AmericanGut 13.333 %   0.033 %  0.038 % 2.0 15
BiomeSight 11.648 %   0.005 %  0.013 % 345.0 2962
bugspeak 100 %   0.133 %  % 1.0 1
CerbaLab 66.667 %   0.005 %  0 % 2.0 3
custom 14.754 %   0.19 %  0.069 % 9.0 61
es-xenogene 100 %   0.157 %  0.16 % 29.0 29
Medivere 57.143 %   0.001 %  0.001 % 4.0 7
SequentiaBiotech 5.556 %   0.023 %  0.01 % 2.0 36
Thorne 86.139 %   0.044 %  0.112 % 87.0 101
Thryve 21.67 %   0.003 %  0.002 % 301.0 1389
Tiny 50 %   0.011 %  % 1.0 2

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Diet Style high-fat diets 1 Studies recorded. The consensus is Decreases👶, Click for details.
Prescription - Other metformin (prescription) 1 Studies recorded. The consensus is Increases👶, Click for details.
Probiotics Prescript Assist (2018 Formula) 1 Studies recorded. The consensus is Increases👶, Click for details.

Foods Containing the Streptomyces bacteria

Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.

Pecorino(Italian Cheese) Weight: 0.3356 yoghurt fermentation Weight: 0.2063 Piedmont hard cheese Weight: 0.1703 Beer Sour Flanders Red Ale Weight: 0.07822 Lard Farm Weight: 0.07578 Betlehem cheese Weight: 0.06937 Fermented finger millet Weight: 0.007212 Motoho fermented 72h, South Africa Weight: 0.006525 Gappal seche, Burkina Faso Weight: 0.006141 Sausage, Cyprus: Limassol Weight: 0.00488

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.